GE HealthCare Technologies Inc. $GEHC Shares Sold by Sippican Capital Advisors

Sippican Capital Advisors decreased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 38.3% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 10,088 shares of the company’s stock after selling 6,259 shares during the quarter. Sippican Capital Advisors’ holdings in GE HealthCare Technologies were worth $747,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. raised its holdings in shares of GE HealthCare Technologies by 49.9% during the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after acquiring an additional 1,711,963 shares during the period. Nuveen LLC purchased a new stake in shares of GE HealthCare Technologies in the first quarter valued at about $77,058,000. Eminence Capital LP increased its position in GE HealthCare Technologies by 38.7% during the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after purchasing an additional 507,101 shares during the last quarter. Homestead Advisers Corp boosted its holdings in GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after purchasing an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board boosted its holdings in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after purchasing an additional 409,636 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 4.3%

GE HealthCare Technologies stock opened at $71.01 on Friday. The company has a market capitalization of $32.42 billion, a PE ratio of 14.55, a price-to-earnings-growth ratio of 2.71 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm has a 50 day moving average price of $74.31 and a 200 day moving average price of $72.28.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the prior year, the firm earned $1.00 earnings per share. The firm’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is currently 2.87%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. BTIG Research reiterated a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a report on Thursday, September 18th. Weiss Ratings reiterated a “hold (c)” rating on shares of GE HealthCare Technologies in a report on Saturday, September 27th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Finally, Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Six equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $85.78.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.